These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 28361737)

  • 21. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
    Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
    Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
    Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
    Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings.
    Sloan DJ; Lewis JM
    Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):163-72. PubMed ID: 26884496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Bonnet M; Bastard M; du Cros P; Khamraev A; Kimenye K; Khurkhumal S; Hayrapetyan A; Themba D; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):177-86. PubMed ID: 26792469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries.
    Chiang CY; Lin CJ
    Indian J Tuberc; 2020 Dec; 67(4S):S16-S22. PubMed ID: 33308663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
    Wirth D; Dass R; Hettle R
    BMC Health Serv Res; 2017 Mar; 17(1):182. PubMed ID: 28270207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
    Guglielmetti L; Ardizzoni E; Atger M; Baudin E; Berikova E; Bonnet M; Chang E; Cloez S; Coit JM; Cox V; de Jong BC; Delifer C; Do JM; Tozzi DDS; Ducher V; Ferlazzo G; Gouillou M; Khan A; Khan U; Lachenal N; LaHood AN; Lecca L; Mazmanian M; McIlleron H; Moschioni M; O'Brien K; Okunbor O; Oyewusi L; Panda S; Patil SB; Phillips PPJ; Pichon L; Rupasinghe P; Rich ML; Saluhuddin N; Seung KJ; Tamirat M; Trippa L; Cellamare M; Velásquez GE; Wasserman S; Zimetbaum PJ; Varaine F; Mitnick CD
    Trials; 2021 Sep; 22(1):651. PubMed ID: 34563240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classifying new anti-tuberculosis drugs: rationale and future perspectives.
    Tiberi S; Scardigli A; Centis R; D'Ambrosio L; Muñoz-Torrico M; Salazar-Lezama MÁ; Spanevello A; Visca D; Zumla A; Migliori GB; Caminero Luna JA
    Int J Infect Dis; 2017 Mar; 56():181-184. PubMed ID: 27818361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.
    Lange C; Chesov D; Heyckendorf J; Leung CC; Udwadia Z; Dheda K
    Respirology; 2018 Jul; 23(7):656-673. PubMed ID: 29641838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of multidrug-resistant tuberculosis in the 21st century.
    Kaul G; Kapoor E; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Mar; 55(3):215-224. PubMed ID: 30938375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.